These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7794746)

  • 1. Trisomy 11: an association with stem/progenitor cell immunophenotype.
    Slovak ML; Traweek ST; Willman CL; Head DR; Kopecky KJ; Magenis RE; Appelbaum FR; Forman SJ
    Br J Haematol; 1995 Jun; 90(2):266-73. PubMed ID: 7794746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
    Alsabeh R; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
    Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
    Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission.
    Engel H; Goodacre A; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Andreeff M
    Br J Haematol; 1997 Oct; 99(1):64-75. PubMed ID: 9359505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells.
    Engel H; Drach J; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Goodacre A; Andreeff M
    Leukemia; 1999 Apr; 13(4):568-77. PubMed ID: 10214863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trisomy 21 as the sole acquired karyotypic abnormality in acute myeloid leukemia and myelodysplastic syndrome.
    Wan TS; Au WY; Chan JC; Chan LC; Ma SK
    Leuk Res; 1999 Nov; 23(11):1079-83. PubMed ID: 10576514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features.
    Wang SA; Jabbar K; Lu G; Chen SS; Galili N; Vega F; Jones D; Raza A; Kantarjian H; Garcia-Manero G; McDonnell TJ; Medeiros LJ
    Leukemia; 2010 Apr; 24(4):740-7. PubMed ID: 20072149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11.
    Caligiuri MA; Strout MP; Schichman SA; Mrózek K; Arthur DC; Herzig GP; Baer MR; Schiffer CA; Heinonen K; Knuutila S; Nousiainen T; Ruutu T; Block AW; Schulman P; Pedersen-Bjergaard J; Croce CM; Bloomfield CD
    Cancer Res; 1996 Mar; 56(6):1418-25. PubMed ID: 8640834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes.
    Paulsson K; Johansson B
    Pathol Biol (Paris); 2007 Feb; 55(1):37-48. PubMed ID: 16697122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and morphological features of cases of trisomy 13 in acute non-lymphocytic leukemia.
    Soni M; Brody J; Allen SL; Schulman P; Kolitz J; Rai K; Broome JD; Koduru PR
    Leukemia; 1996 Apr; 10(4):619-23. PubMed ID: 8618437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
    Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
    Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trisomy 19 as the sole chromosomal anomaly in hematologic neoplasms.
    Johansson B; Billström R; Mauritzson N; Mitelman F
    Cancer Genet Cytogenet; 1994 May; 74(1):62-5. PubMed ID: 8194050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisomy 11 acute myeloid leukemia: 5 additional cases from the Japan Adult Leukemia Study Group AML-92 and AML-95 databases.
    Suzuki A; Ohyashiki K; Kimura Y; Yamada H; Sano F; Miyawaki S; Kuriyama K; Ohno R;
    Int J Hematol; 2000 Dec; 72(4):466-9. PubMed ID: 11197213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients.
    Casasnovas RO; Campos L; Mugneret F; Charrin C; Béné MC; Garand R; Favre M; Sartiaux C; Chaumarel I; Bernier M; Faure G; Solary E
    Leukemia; 1998 Jan; 12(1):34-43. PubMed ID: 9436918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
    Davey FR; Abraham N; Brunetto VL; MacCallum JM; Nelson DA; Ball ED; Griffin JD; Baer MR; Wurster-Hill D; Mayer RJ
    Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trisomy 6 as a primary karyotypic aberration in hematologic disorders.
    Mohamed AN; Varterasian ML; Dobin SM; McConnell TS; Wolman SR; Rankin C; Willman CL; Head DR; Slovak ML
    Cancer Genet Cytogenet; 1998 Oct; 106(2):152-5. PubMed ID: 9797781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: study of nine cases.
    Cuneo A; Ferrant A; Michaux JL; Bosly A; Chatelain B; Stul M; Dal Cin P; Dierlamm J; Cassiman JJ; Hossfeld DK; Castoldi G; Van den Berghe H
    Cancer Genet Cytogenet; 1996 Nov; 92(1):31-6. PubMed ID: 8956868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration.
    Paulsson K; Heidenblad M; Strömbeck B; Staaf J; Jönsson G; Borg A; Fioretos T; Johansson B
    Leukemia; 2006 May; 20(5):840-6. PubMed ID: 16498392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group.
    Schoch C; Haase D; Fonatsch C; Haferlach T; Löffler H; Schlegelberger B; Hossfeld DK; Becher R; Sauerland MC; Heinecke A; Wörmann B; Büchner T; Hiddemann W
    Br J Haematol; 1997 Dec; 99(3):605-11. PubMed ID: 9401073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.